|
HS Code |
148864 |
| Chemical Name | (+)-Gallocatechol |
| Synonyms | cis-1,2,3-Trihydroxy-5-(3,4,5-trihydroxyphenyl)cyclohexa-3,5-diene |
| Molecular Formula | C6H6O4 |
| Molecular Weight | 142.11 g/mol |
| Cas Number | 603-70-9 |
| Appearance | White to off-white powder |
| Melting Point | 145-147°C |
| Solubility | Soluble in water, methanol, and ethanol |
| Optical Rotation | [α]D +14.5° (c=1, H2O) |
| Boiling Point | Decomposes before boiling |
| Structure Type | Flavan-3-ol catechol derivative |
| Pubchem Cid | 65084 |
As an accredited (+)-Gallocatechol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | (+)-Gallocatechol is packaged in a sealed, amber glass bottle containing 1 gram, labeled with product details, hazard symbols, and batch information. |
| Shipping | Shipping for (+)-Gallocatechol is conducted in compliance with all relevant chemical transport regulations. The compound is securely packed in sealed containers to prevent contamination, moisture, and degradation. Temperature and handling instructions are strictly followed to ensure safety and product integrity during transit. Shipping documents and Safety Data Sheets are included. |
| Storage | (+)-Gallocatechol should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, well-ventilated area, ideally at 2–8°C (refrigerated). Avoid exposure to heat, air, and strong oxidizing agents to prevent degradation. Proper labeling and segregation from incompatible substances are important for safety and chemical stability during storage. |
Competitive (+)-Gallocatechol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer, the route from raw feedstock to high-purity (+)-Gallocatechol passes through many hands, all guided by deep technical expertise and straight talk from years on the plant floor. Our production teams started working with gallocatechol long before it gained traction in research circles, and every batch tested since then strengthened our understanding of its distinct molecular behavior. This hands-on journey shaped our appreciation for the molecule’s stereochemistry and how minor shifts in processing can influence the crystalline form, solubility, and ultimately the performance in downstream applications.
We manufacture (+)-Gallocatechol with a focus on structural fidelity and stereochemical purity. This compound stands apart thanks to its specific chirality, which distinguishes it sharply from its racemic counterparts. Racemic gallocatechols, or those produced from non-enantioselective chemistry, present a mixture of enantiomers, blunting the performance in chiral-sensitive studies and enzymatic reactions. We make single-enantiomer (+)-Gallocatechol by leveraging asymmetric synthesis routes, implemented at scale with robust controls at each step. The process starts from bio-based catechins, moving through selective oxidation and crystallization without introducing metal contaminants. This choice sidesteps the off-flavors and trace impurities that show up if other oxidizing agents are used, particularly in food-contact or pharmaceutical workflows.
We see specifications as more than a set of numbers–they reflect deliberate choices about how far to refine and purify. Our (+)-Gallocatechol reaches over 99% enantiomeric excess, confirmed by chiral HPLC. Moisture control remains a production challenge for polyphenols like this, so every drum and bottle contains material dried on-site over inert gas, yielding a consistent off-white to tan crystalline powder that dissolves easily in water and polar solvents. The melting range, a tight 241-243°C, acts as a fast visual check for purity, which our line workers and QC staff routinely use before more resource-intensive chromatographic analysis.
We avoid broad “specification” language because experience teaches that subtle differences in impurity profiles—or overlooked process variables—can turn a promising experiment into a waste of funding. Our chemical engineers track trace-element uptick from vessel wear, we validate our final product against an in-house IR reference, and QA reviews both the spectral fingerprint and the microbial counts for consistency. This has proven especially important when supporting research that drifts between analytical, preclinical, and pilot production settings.
Customers reach out for (+)-Gallocatechol for uses stretching across chiral pharmacology, antioxidant mechanism studies, and as a reference substance in advanced analytical labs. Our feedback shows that enantiopure gallocatechol gets selected whenever the bioactivity of one isomer must be clarified—such as in enzyme inhibition kinetics or nanomaterial surface grafting—while racemic blends see uptake mostly in less sensitive screening or routine QC work. Teams studying flavonoid biosynthesis, free-radical scavenging, or cellular protective pathways value the single chirality because they rely on repeatable, interpretable biochemical interactions.
Pharmaceutical process chemists put our material through paces in asymmetric catalytic evaluation, using the (+)-isomer to model substrate specificity or drug metabolite mimicry. Research units in academic and industry labs keep it as a calibration or validation standard: a known entity that verifies chromatography system integrity, especially in regulation-bound analytical environments. Recent years brought uptake from environmental toxicology labs as well, where (+)-Gallocatechol acts as a probe for soil or water pollutant degradation pathways thanks to its sensitivity in oxidative stress testing.
Difference begins at the bench and runs all the way to the final drum. Bulk gallocatechol circulating through intermediaries often shows variable moisture content, broad melting points, and mixed isomer ratios; we avoid this by manufacturing everything at our own site, where the entire synthesis and purification train remains under one roof. Our reactors stay dedicated to specific product lines, sharply reducing risk of cross-contamination with structurally similar phenolics or tannins. Production batches align with project needs, minimizing residence time in bags and reducing the risks of degradation or color formation that can plague long-shelflife inventories shipped by traders.
Our analytical teams run every finished lot through multi-method identity checks, spanning chiral HPLC, UV-vis analysis, and NMR. We dig deeper if inconsistencies show up, cross-referencing with globally recognized standards organizations and tweaking our crystallization steps seasonally to dampen temperature and humidity swings. By pooling real-time process feedback, we tighten reproducibility and give customers a more transparent window into the batch’s origin and traceability.
Experience in chemical manufacturing has made us skeptical of shortcuts and fast fixes. We noticed too many supply chains passing off brown, clumpy residues under the guise of “high purity” phenolics, where unchecked side reactions left odd colors, fluctuating solubility, or unidentified trace contaminants. All of these bottleneck downstream R&D or require added sample cleanup. By building tighter controls on our own end, and removing heavy metals and process residues before crystallization, we supply a product that slots directly into both green chemistry projects and regulated process development.
Sustainable manufacturing choices drive part of our production approach. During scale-up, our engineering staff recapture solvents, implement closed-cycle water rinsing, and maximize yield from bio-based catechin feedstocks sourced from renewable origins. Instead of sending oxidant byproducts down the drain, we convert them to safe, reusable intermediates, redirecting surplus streams into less sensitive industries. These changes stem from practical necessity—nobody wants to burden their facility with excess waste handling costs. The resulting product serves clean-tech researchers who require nontoxic, low-residue reagents in emerging areas like catalysis, electronic sensing platforms, and innovative polymer design.
For seasoned chemists, the frustration of running controls with an off-grade standard is all too familiar: chromatograms drift, peak tails cloud precision, and one suspects solvents are to blame, only to trace the error to the starting material. Taking shortcuts on purity or isomer ratio pushes those problems downstream. Our experience reinforces the value of investigating every “bad spot” on a TLC plate, especially with polyphenolic standards whose high reactivity invites decomposition.
Our staff’s commitment translates into a product that resists air oxidation longer, stays clear in solution during kinetic work, and behaves consistently from one vial to the next. Researchers, in turn, build more reliable kinetic models and reference curves, shaving days off troubleshooting when they don’t have to chase down artifacts in sample runs. Beyond the research-tier impact, this approach reduces headache in scale-up and pilot plant transitions, where tight process control and minimized variance yield cost efficiencies over “cheapest available” raw chemistries.
The research community faces a reproducibility crisis, and impurity-laden chemicals quietly fuel much of it. We stepped in by customizing our (+)-Gallocatechol line for long-term stability and batch-to-batch similarity—choosing packaging materials based on vapor transmission, adding tamper seals, and extending shelf life with vacuum-packing under inert gas. Customers noticed that sample-to-sample drift faded: reference values tracked within analytical error, and methods transferred cleanly across sites.
Our manufacturing lab participates in inter-laboratory calibration studies, often using our own gallocatechol as a test compound for blind surveys. Internal audits investigate outlier results, sometimes tracing them to vendor-supplied upstream material; these experiences cemented our belief that direct production, versus blending secondary sources, lays the ground for reproducible science. By sharing analytical tracebacks and batch data on request, we keep research teams in the driver’s seat: full transparency on origin, composition, and any process deviations.
Discussions with customers reveal a recurring pain point—generic, lower-cost gallocatechol often arrives with unpredictable behavior. Some users report spontaneous browning in storage, erratic solubility, or interference during UV/VIS or HPLC quantification. In our facility, every deviation triggers backtracking that pinpoints its root, whether it’s a missed filtration or a temperature swing during drying. Competing materials, typically aggregated from multiple origins, get blended without harmonizing isomer composition or rigorously testing for secondary oxidative byproducts. In fact, our analyses of market samples revealed contaminants ranging from simple sugars to transition metals—culprits for unexpected chemical shifts and UV background.
Our (+)-Gallocatechol maintains identity, purity, and physical consistency across lots because of a strict, vertically-integrated production pathway. Staff monitor reactor profiles and storage stability, feeding process learnings back into real-time synthesis controls. The difference plays out directly in reproducibility and customer feedback: university teams send us comparative data tracking solution stability, melting point consistency, and chromatographic behavior, consistently ranking our product above both regional and overseas competitors in analytical reliability.
Our days are spent troubleshooting instrumentation, processing orders, and sometimes—unavoidably—handling last-minute rush shipments for urgent studies. Through all this, the applications that most benefit from single-enantiomer, high-purity (+)-Gallocatechol remain those demanding analytical sharpness: pharmacokinetic modeling, antioxidant testing, high-throughput screening, and mechanistic evaluation in biochemistry and nanoscience. Synthetic chemists use our product to benchmark reaction selectivity in asymmetric catalysis, while formulation labs depend on predictable color and clarity in both model and real matrices.
Multifunctional research facilities take advantage of the material’s robust solubility profile, consistent UV absorbance, and resistance to premature oxidation in open-air setup. For teams driving structure-activity relationship (SAR) explorations or deep mechanistic studies, this level of consistency removes a major variable, aiding clear peer review and publication. We know, because our product has been checked—and cited—in peer-reviewed studies, with staff contributing technical details directly to user protocols, even troubleshooting projects where batch inconsistencies elsewhere had held research back for months.
Anyone who’s worked in a chemical plant recognizes that customer service starts at the process end—not the sales floor. Our technical support staff draw directly from the lab and plant operators, giving real-world advice for handling, storage, and process upscaling. Questions about solubility, batch preparation, packaging, and long-term stability get answers grounded in practical, not just theoretical, experience. Many customers ask about re-crystallization, co-solvent compatibility, and how to avoid oxidation during storage; our recommendations reflect trial-and-error from our own operations, including optimal desiccants, agitation protocols, and controlled-access dry rooms.
As a production-site manufacturer, we see challenges before they hit the market. Moisture ingress during spring rains, for example, changes product handling needs, so we timed our packaging to those rhythms. If a batch strays from standard analytical criteria, we quarantine it and inform affected users, opting for traceability over face-saving. Collegiality and straight answers—without hiding behind layered intermediaries or “product codes”—set us apart, especially in academic and industrial projects needing collaborative troubleshooting.
Each tonne of (+)-Gallocatechol produced, checked, and shipped reflects years spent fine-tuning both the synthesis itself and the controls wrapped around it. Our team understands first-hand how minor side reactions or impurities complicate both fundamental research and advanced process development. The reliability in pharmacological testing, environmental assay, and synthetic method benchmarking stems directly from the single-enantiomer composition, clean impurity profile, and our readiness to provide authentication data on demand.
Standardization carries an added benefit rarely stated outright: it accelerates method transfer, sharpens peer review, and smooths the regulatory pathway in drug-development environments. Our customers value being able to trace their material back to a single-source infrastructure, seeing as much of the process as they need for confidence in their results. Small-volume, high-purity production wins out every time over mass-produced, blended alternatives in these situations—especially where expensive project timelines ride on every outcome.
Manufacturing is a learning loop. Changes in downstream user demand, new regulatory insights, or fresh technical hurdles don’t just ripple—they trigger improvements. Feedback from pilot-scale pharmaceutical engineers prompted tweaks to drying and filtration steps, making the product even more suitable as a reference-grade input. We have grown the (+)-Gallocatechol line by responding to actual pain points: requests for less glassy residue, tighter granulation, faster dissolution, or added trace-authenticity reporting. Adjustments in analytical methods, raw material traceability, and packaging have all traced back to direct user experience, not just abstract quality system mandates.
Lessons learned in production often translate directly into R&D. We initiated a regular round-table between plant chemists and analysts from partner research groups. Problems like chiral drift, peak tailing, or unexpected precipitates led to improved stability steps, more transparent batch release criteria, and even upgraded plant infrastructure to prevent accidental cross-exposure to other phenolics. This feedback loop underpins our approach to (+)-Gallocatechol’s production, finishing, and delivery—results refined by constant user engagement.
Some see fine-chemical production as routine; in our experience, supporting every phase of innovation—from proof-of-concept screening to process validation—demands a different mindset. The value our production model brings isn’t just high-purity, enantiomer-selective (+)-Gallocatechol, but a transparent partnership where researchers, engineers, and formulators rely on the consistent quality they receive each time. Labs driving new projects, scale-ups, or regulatory filings all demand that their input materials won’t throw a wrench into their planned outcomes. We built our systems to serve that expectation, and we keep evolving them as new uses and needs arise.
The story of our (+)-Gallocatechol line is one of hands-on learning, technical rigor, and mutual trust with scientific users. Years of improvement and relentless focus on both strict purity and repeatable stereochemistry made possible a product that stands out in advanced analytical, pharmacological, and materials-science labs. As chemical producers, our commitment runs from molecular control to supply chain transparency, blending real-world experience with a mission to enable sound, reproducible research.